Global Fatty Liver Day is on June 12 – There’s Still Time to Get Involved!

I recently conducted a workshop titled: Advanced Strategies: Navigating Credible Research and Accessing Clinical Trial Opportunities, as part of GLI’s A4 ,program with a focus on clinical research participation.

Global Liver Institute is excited to announce the appointment of Dr. Sharon Jaycox as the new Fatty Liver Disease Program Director.

As of January 2025, major changes to Medicare Part D under the Inflation Reduction Act are now in effect, making prescription drugs more affordable for millions of patients.

As of January 2025, major changes to Medicare Part D under the Inflation Reduction Act are now in effect, making prescription drugs more affordable for millions of patients.

Last month, the GLI team proudly attended AASLD’s The Liver Meeting™, starting with our 10th anniversary celebration, which brought together patient advocates, industry leaders, and liver community members to celebrate a decade of impactful work.